Novel stem cell therapy repairs 'irreversible' corneal damage in clinical trial
Science Daily: Pharmacology News
MARCH 4, 2025
Results from a phase 1/2 clinical trial of a novel stem cell treatment for cornea injuries found 14 patients treated and tracked for 18 months had a more than 90% success rate at restoring the cornea's surface and improvements in vision.
Let's personalize your content